ICU Medical (NASDAQ:ICUI) Stock Rating Upgraded by StockNews.com

ICU Medical (NASDAQ:ICUI - Get Free Report) was upgraded by equities research analysts at StockNews.com from a "hold" rating to a "buy" rating in a note issued to investors on Wednesday.

Several other research firms also recently commented on ICUI. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Raymond James set a $97.00 price target on ICU Medical in a research note on Wednesday, March 12th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, ICU Medical presently has an average rating of "Buy" and an average target price of $168.67.

ICU Medical Stock Performance

Shares of ICUI stock traded down $0.47 during midday trading on Wednesday, hitting $138.67. 205,209 shares of the company were exchanged, compared to its average volume of 270,759. ICU Medical has a 52 week low of $93.36 and a 52 week high of $196.26. The firm has a market capitalization of $3.40 billion, a P/E ratio of -30.34 and a beta of 0.86. The firm's 50 day moving average price is $146.34 and its two-hundred day moving average price is $159.60. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

Institutional Investors Weigh In On ICU Medical

Hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its position in shares of ICU Medical by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier's stock worth $416,176,000 after purchasing an additional 17,805 shares during the period. JPMorgan Chase & Co. increased its holdings in ICU Medical by 7.4% in the 4th quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier's stock worth $109,920,000 after purchasing an additional 49,108 shares in the last quarter. Geode Capital Management LLC raised its holdings in ICU Medical by 9.6% in the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock valued at $99,687,000 after buying an additional 48,106 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of ICU Medical by 18.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier's stock worth $83,788,000 after purchasing an additional 82,982 shares during the period. Finally, Northern Trust Corp lifted its holdings in ICU Medical by 11.1% during the 4th quarter. Northern Trust Corp now owns 402,342 shares of the medical instruments supplier's stock worth $62,431,000 after buying an additional 40,187 shares during the period. 96.10% of the stock is currently owned by institutional investors and hedge funds.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.